HartfordBusiness.com recently published a Q&A with Cybrexa's Per Hellsund about fundraising, and finding success in biotech startups. Read the full article here....read more
Read the write-up about Cybrexa's cancer treatment breakthrough in Yale's Centerpoint...read more
Financing supports development of new class of cancer therapies. New Haven, Conn., June __, 2017 Cybrexa Therapeutics, a start-up cancer therapeutics company, announced today that it has secured a Series B round of financing in the amount of $6 million. Connecticut...read more
Below are links to coverage of the high-impact DNA repair research findings by our Scientific Founders.
5 Science Park 395 Winchester Ave. New Haven, CT 06511 (860) 717-2731